Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S, F.C.P.S , M.C.P.S
Internal Medicine Specialist
M.B.B.S, F.C.P.S. ( MEDICINE )
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Diabetologist
MBBS, FCPS , MRCP, MRCP (UK), SCE Endocrinology and Diabetes (UK)
Gastroenterologist
MBBS ( Gold Medalist), FCPS (Gastroenterology), MRCP-1 [UK]
Gastroenterologist
MBBS ( Gold Medalist), FCPS (Gastroenterology), MRCP-1 [UK]
Endocrinologist
MBBS, FCPS (Medicine), MRCP ( UK )
Diabetologist
M.B.B.S, M.D (Medicine)
Internal Medicine Specialist
M.B.B.S., Diplomate of American Board (Internal Medicine)
Internal Medicine Specialist
M.B.B.S., Diplomate of American Board (Internal Medicine)
Endocrinologist
M.B.B.S., F.C.P.S. (Medicine), F.C.P.S. (Endocrinologist)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), MRCEM
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures